by Paul Krzyzanowski | May 1, 2012
Commercialization plenary summary, part 1 of 4 Till and McCulloch Meeting (#TMM2012) attendees in Montreal had the opportunity to hear from four speakers involved in commercializing discoveries in regenerative medicine, from the perspectives of not-for-profit,...
by Paul Krzyzanowski | Mar 27, 2012
Without a doubt, scientific research has the potential to discover new knowledge that can be used to improve human life. New tools and new ways of doing things are constantly being developed or invented, but arguably need to be commercialized before their benefits...
by Angela C. H. McDonald | Mar 21, 2012
Titanium can be found everywhere. It is used in cars, sporting equipment and even jewelry manufacturing. But did you know that titanium products are used inside the human body? You may know someone who has undergone a joint replacement procedure or someone who has a...
by Paul Krzyzanowski | Jan 24, 2012
Repurposing known drugs for new applications is a strategy with fascinating potential, with two of the most notable examples being Thalidomide and Viagra. Thalidomide was commonly used in the late 1950s as a sedative in pregnant women, later being associated with...
by David Kent | Nov 17, 2011
While many researchers will feel disheartened by last month’s ruling in the Court of Justice of the European Union that prohibits scientific research patents on human embryonic stem cell products (see Ubaka Ogbogu’s article), it seems some positive news is emerging...
by Paul Krzyzanowski | Oct 27, 2011
Canada was built upon the inventiveness and resourcefulness of people who lived here. Why then, have Canadians long heard and read about being second best, sellouts, and in general not that great? Thinking we aren’t competitive has almost become a national mantra. But...
Comments